CNS Pharmaceuticals, Inc. (CNSP) stock

CNSPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 5/30

$2.89−0.73 (-20.17%)

Close on Nov 13, 2026Market cap $4.22MP/E –Yield –

CNS Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

CNS Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?